The Competition Tribunal ruled in favor of a lawsuit by Laboratorio Lafi Ltda. against Laboratorio Novartis Chile S.A., for disloyal competition acts consisting of comparative publicity regarding a particular medicine. The Tribunal stated that Novartis had market power in the market of that medicine, and therefore could engage in disloyal competition acts with the object of reaching, maintaining or augmenting a dominant position.
The defendant had to pay a fine of 200 Monthly Tributary Units (around US$ 15,000).